Contribution of 18F-FDG PET/CT on non-operated prosthetic valve infective endocarditis follow-up
Creators
- 1. Aix-Marseille Univ, CNRS, centrale Marseille, institut Fresnel, Marseille (France)
- 2. IHU hopital de la Timone, CHU Marseille, AP-HM, 264, rue Saint-Pierre, 13005 Marseille (France)
- 3. Service de cardiologie hopital de la Timone, CHU de Marseille, AP-HM, 264, rue Saint-Pierre, 13005 Marseille (France)
Description
Introduction. - Prosthetic valve endocarditis is a diagnostic and therapeutic challenge; 18F-FDG PET/CT has seen increasing use and has been incorporated in the latest ESC endocarditis guidelines. Follow-up by PET/CT has never been studied. The aim was to study the use of PET/CT to help predicting recurrences after full antibiotic treatment. Methods. - From January 2011 to April 2016, all patients presenting with definite or possible prosthetic valve endocarditis were included and had a PET/CT after admission. After discharge, non-operated patients had a second PET/CT from 6 to 10 weeks after the end of intravenous antibiotic treatment, in addition to clinical and echocardiographic follow-up. Results. - Among 276 patients with prosthetic valve admitted for suspicion of infective endocarditis, 43 of them with an abnormal prosthetic uptake on the first PET/CT had a second PET/CT within a mean period of 67.3 days after the end of intravenous antibiotic treatment. The mean follow-up was 414 days. Five recurrences occurred among the 34 patients with persistent abnormal prosthetic uptake on second PET/CT, there was no recurrence among the nine patients who had no more abnormal prosthetic uptake. Conclusion. - This is the first study to evaluate the potential benefits of PET/CT for medically treated PVE follow-up. All recurrences occurred among patients with persistent abnormal prosthetic uptake on second PET/CT. An unexpected finding was the potential of bone-marrow and splenic uptake evolution, which is underused in IE and showed an interesting potential in the prognosis of these patients. (authors)
Availability note (English)
Available from doi: http://dx.doi.org/10.1016/j.mednuc.2018.02.005Abstract (French)
Introduction. - L'endocardite infectieuse sur prothese valvulaire est un challenge diagnostique et therapeutique. La TEP/TDM au 18F-FDG apporte une aide considerable dans ce domaine et fait desormais partie des criteres majeurs diagnostiques dans les recommandations de l'ESC de 2015. L'utilite potentielle de cet examen dans le suivi des patients reste a demontrer. L'objectif principal de l'etude etait d'etudier l'impact pronostique en termes de recidive de la negativation ou de la persistance d'une positivite de la TEP/TDM de controle apres traitement antibiotique. Materiels et methodes. - De janvier 2011 a avril 2016, etaient retrospectivement inclus, a partir d'une cohorte, les patients presentant une endocardite infectieuse sur prothese valvulaire certaine ou possible qui beneficiaient d'une premiere TEP/TDM. Six a 10 semaines apres la fin de l'antibiotherapie, les patients non operes beneficiaient d'une TEP/TDM de controle, en plus d'une echocardiographie et d'une consultation clinique. Resultats. - Parmi les 276 patients porteurs d'une PV ayant beneficie d'une TDM initiale pour suspicion d'endocardite infectieuse, 43 patients avec une TEP/TDM1 positive sur PV ont pu beneficier d'une TEP/TDM de controle. Le suivi moyen etait de 414 jours. Trente-quatre patients presentaient une hyperfixation persistante sur prothese valvulaire sur TEP/TDM de controle. Les cinq recidives concernaient des patients avec TEP/TDM de controle positive sur prothese valvulaire. Conclusion. - Il s'agit de la premiere etude a evaluer les apports de la TEP/TDM dans le suivi des endocardites infectieuses sur protheses valvulaires non operees traitees medicalement. La totalite des recidives survenait chez des patients ayant une fixation prothetique persistante apres l'arret de l'antibiotherapie. Notre etude montrait egalement une tendance prometteuse sur le suivi des marqueurs indirects d'inflammation que sont les fixations spleniques et osteomedullaires qui semblaient associes a un risque accru de recidive. (auteurs)Additional details
Additional titles
- Original title (French)
- Apport de la TEP/TDM au 18F-FDG dans le suivi des endocardites infectieuses sur protheses valvulaires non operees
Identifiers
Publishing Information
- Journal Title
- Medecine Nucleaire. Imagerie Fonctionnelle et Metabolique
- Journal Volume
- 42
- Journal Issue
- no.2
- Journal Page Range
- p. 59-69
- ISSN
- 0928-1258
- CODEN
- MNIMEX
INIS
- Country of Publication
- France
- Country of Input or Organization
- France
- INIS RN
- 53087590
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ANTIBIOTICS; BONE MARROW; FLUORINE 18; PATIENTS; POSITRON COMPUTED TOMOGRAPHY; RECOMMENDATIONS; UPTAKE; VALVES
- Descriptors DEC
- ANIMAL TISSUES; ANTI-INFECTIVE AGENTS; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; COMPUTERIZED TOMOGRAPHY; CONTROL EQUIPMENT; DIAGNOSTIC TECHNIQUES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; EQUIPMENT; FLOW REGULATORS; FLUORINE ISOTOPES; HEMATOPOIETIC SYSTEM; HOURS LIVING RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LIGHT NUCLEI; NANOSECONDS LIVING RADIOISOTOPES; NUCLEI; ODD-ODD NUCLEI; ORGANIC COMPOUNDS; ORGANS; RADIOISOTOPES; TOMOGRAPHY
Optional Information
- Notes
- 35 refs.